Название продукции:4-(2-CYANOPROPAN-2-YLAMINO)-2-FLUORO-N-METHYLBENZAMIDE

IUPAC Name:4-[(1-cyano-1-methylethyl)amino]-2-fluoro-N-methylbenzamide

CAS:915087-32-0
Молекулярная формула:C12H14FN3O
Чистота:95%+
Номер в каталоге:CM329948
Молекулярная масса:235.26

Упаковочная единица Доступно для заказа Цена ($) Количество
CM329948-100mg in stock ǠŸǠ
CM329948-250mg in stock œŸǠ
CM329948-1g in stock ŸȤdž
CM329948-5g 1-2 Weeks ǠƚşǠ

Только для использования в НИОКР..

Форма запроса

   refresh    

Информация о продукции

Номер CAS:915087-32-0
Молекулярная формула:C12H14FN3O
Точка плавления:-
Smiles-код:O=C(NC)C1=CC=C(NC(C)(C#N)C)C=C1F
Плотность:
Номер в каталоге:CM329948
Молекулярная масса:235.26
Точка кипения:
Номер Mdl:
Хранение:

Column Infos

Enzalutamide
Aug. 23, 2023, FDA grants priority review for XTANDI(enzalutamide) in non-metastatic castration-sensitive prostate cancer with high-risk biochemical recurrence.
XTANDI (enzalutamide) is an androgen receptor signaling inhibitor. Androgen receptor inhibitors interfere with the connection between androgens and androgen receptors. This can help slow cancer cell growth.XTANDI is currently approved for one or more of these indications in more than 100 countries, including in the U.S., European Union and Japan. Over one million patients have been treated with XTANDI globally.